Promise and perils for patients and physicians

Article Abstract:

The Medicare Prescription Drug Improvement and Modernization Act (MMA) will come into effect on January 1, 2006 for the benefit of 42 million Medicare beneficiaries and their physicians, with most states having roughly 15 plans offered by private companies including different premiums, and copayments. However, certain complexities exist such as patients have to sign up for one of several plans, the failure of which will result in an increment in future premiums for each month of delay.

Drugs Reimbursement Benefits, Prescription drug plans

---

Dramatic improvement or death spiral: two members of Congress assess the Medicare bill

Article Abstract:

Bill Thomas, chairman of the House Ways and Means Committee, California and Senator Edward M. Kennedy, Massachusetts discuss the Medicare bill passed in 2004. President George W. Bush vowed to veto any bill that would limit seniors' choices or take away their drug coverage, thus Congress transformed Medicare, as its core, from a bill-paying program for sick patients to one designed to keep seniors healthy.

---

The new Medicare prescription-drug benefit: a pure power play

Article Abstract:

The political highlights of a Medicare bill such as the evolution of law, the scope of the drug benefit, drug-discount cards, are discussed. According to the bill, 41.7 million disabled and elderly beneficiaries of Medicare will have new coverage of prescription drugs.

Similar abstracts:

• Abstracts: Patients, physicians fall short in optimal prevention of diabetes complications. Dash of dissent on salt intake advice
• Abstracts: High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy
• Abstracts: Pregnancy as a tissue expander in the correction of a scar deformity. Embryonal sarcoma of the liver in pregnancy, associated with HELLP syndrome
• Abstracts: Improving identification and awareness of hepatitis C. Improving the prevention of cardiovascular disease. Improving medication safety
• Abstracts: Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. Feasibility of eliminating ocular chlamydia trachomatis with repeat mass antibiotic treatments

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.